MelanomaCisplatinAntineoplastic Combined Chemotherapy ProtocolsSkin NeoplasmsMelanoma, ExperimentalAntineoplastic AgentsNeoplasm MetastasisChemotherapy, AdjuvantDacarbazineMART-1 AntigenTreatment OutcomeCombined Modality Therapygp100 Melanoma AntigenCell Line, TumorNevusNevus, PigmentedProto-Oncogene Proteins B-rafSurvival AnalysisNeoplasm StagingDrug Administration ScheduleLung NeoplasmsDisease-Free SurvivalMelanoma, AmelanoticAntigens, NeoplasmUveal NeoplasmsDoxorubicinSurvival RateVinblastineDrug Resistance, NeoplasmCyclophosphamidePrognosisTumor Cells, CulturedMelanoma-Specific AntigensLymphocytes, Tumor-InfiltratingNeoplasm ProteinsCancer VaccinesEtoposideMelanocytesImmunotherapyChoroid NeoplasmsPaclitaxelAntineoplastic Agents, AlkylatingDysplastic Nevus SyndromeInterleukin-2Monophenol MonooxygenaseCarboplatinGene Expression Regulation, NeoplasticDisease ProgressionLymphatic MetastasisNeoadjuvant TherapyAntibodies, MonoclonalNeoplasm Recurrence, LocalTumor Markers, BiologicalPlatinumApoptosisImmunotherapy, AdoptiveNeoplasmsDeoxycytidineImmunohistochemistryOvarian NeoplasmsBreast NeoplasmsIfosfamideDose-Response Relationship, DrugInfusions, IntravenousInterferon-alphaTaxoidsBrain NeoplasmsDrug Screening Assays, AntitumorMice, NudeNeoplasm InvasivenessTime FactorsAntineoplastic Agents, PhytogenicMethotrexateCarcinoma, Non-Small-Cell LungVomitingCarmustineKaplan-Meier EstimateMelaninsEye NeoplasmsBleomycinNeoplasm TransplantationInduction ChemotherapyDrug SynergismMicrophthalmia-Associated Transcription FactorFollow-Up StudiesCell ProliferationCTLA-4 AntigenDrug EvaluationRecombinant ProteinsCell SurvivalClinical Trials as TopicTesticular NeoplasmsAntimetabolites, AntineoplasticNauseaLomustineCarcinoma, Squamous CellHead and Neck NeoplasmsHLA-A2 AntigenSulfonamidesInjections, Intralesional